PR88639

PARIS, 23 March 2021 /PRNewswire=KYODO JBN/ --

    Unither Pharmaceuticals, the Blow-Fill-Seal (BFS) worldwide leader,

provides diagnostic companies with capacity solutions and innovative

technologies for their testing kits (Covid, Flu, etc.).

    With more than 10 million unit-doses manufactured each month for Covid

testing kits, the French CDMO answers to current challenges based on its

sterile unit doses development and manufacturing expertise.

    The use of Blow-Fill-Seal technology, enables RNase-free single doses, that

can also be sterile if necessary.

    Through its 5 BFS plants on three continents (in France, the United States

and China) and a R&D development center, Unither is able to manage the full

development of a diluent or reagent from formulation to production.

    About Unither Pharmaceuticals

    Founded in Amiens, France, in 1993, Unither Pharmaceuticals has become a

worldwide leader in drug manufacturing for generic pharmaceutical companies

including but not limited to, eye drops and respiratory unit doses, saline

solutions, and stick-packs.  

    Unither Pharmaceuticals has 7 manufacturing sites and 1 R&D center located

in France, the United States, China and Brazil. These sites generated a revenue

of €330 million in 2020 with a headcount exceeding 1.600 employees.

    Website : www.unither-pharma.com

    Blow-Fill-Seal :

https://www.unither-pharma.com/technologies-innovations/blow-fill-seal-bfs/?lang=en

    Article :

https://www.unither-pharma.com/news/diluent-or-immuno-reagent-solutions-for-your-diagnostic-testing-kits-covid-flu-etc/?lang=en

    Contact: testing@unither-pharma.com

    Photo:

https://mma.prnewswire.com/media/1471718/Diluent_or_Immuno_Reagent_solutions.jpg

    Logo:

https://mma.prnewswire.com/media/1471719/Unither_Pharmaceuticals_Logo.jpg

    Source: Unither Pharmaceuticals